Coxsackie B virus serology and Type 1 diabetes mellitus: A sytematic review of published case-control studies

Diabetic Medicine

Volumn 21, Issue 6, 2004, Pages 507-514

  Green, J ^a   Casabonne, D ^a   Newton, R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Coxsackievirus infections; Diabetes mellitus Type 1; Enterovirus; Systematic review

Indexed keywords

CONFIDENCE INTERVAL; COXSACKIE VIRUS B; COXSACKIE VIRUS B3; COXSACKIE VIRUS B4; COXSACKIE VIRUS B5; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL LITERATURE; MEDLINE; REVIEW; RISK FACTOR; SEROLOGY; SEROTYPING; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; ODDS RATIO; RESEARCH DESIGN; SEROEPIDEMIOLOGIC STUDIES;

EID: 2942517532     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01182.x     Document Type: Review

References (52)

1. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J et al. Concordance for type 1 (insulin dependent) and type 2 (non insulin dependent) diabetes in a population-based cohort of twins in Finland. Diabetologia 1992; 35: 1060-1067.
2. Kyvik KO, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. Br Med J 1995; 311: 913-917.
3. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type 1 diabetes-the analysis of the data on published incidence trends. Diabetologia 1999; 42: 1395-1403.
4. Todd JA. From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays 1999; 21: 164-174.
5. Gamble DR, Kinsley ML, Fitzgerald MG, Bolton R, Taylor KW. Viral antibodies in diabetes mellitus. Br Med J 1969; 3: 627-630.
6. Gamble DR, Taylor KW. Seasonal incidence of diabetes mellitus. Br Med J 1969; 3: 631-633.
7. Barrett-Connor E. Is Type 1 diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev Infect Dis 1985; 7: 207-215.
8. Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses - some recent developments. Diabetologia 1993; 36: 687-695.
9. Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus. N Engl J Med 1979; 300: 1173-1179.
10. Champsaur HF, Dussaix E, Samolyk D, Fabre M, Bach C, Assan R. Diabetes and Coxsackie virus B5 infection. Lancet 1980; i: 251.
11. Cox DR, Snell EJ. Analysis of Binary Data. London: Chapman & Hall, 1989: 60.
12. Orchard T, Atchison R, Becker D, Rabin B, Eberhardt M, Kuller L et al. Coxsackie infection and diabetes. Lancet 1983; ii: 631.
13. Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Br Med J 1973; 4: 260-262.
14. Huff JC, Hierholzer JC, Farris WA. An 'outbreak' of juvenile diabetes mellitus: consideration of a viral etiology. Am J Epidemiol 1974; 100: 277-287.
15. Nelson PG, Pyke DA, Gamble DR. Viruses and the aetiology of diabetes: a study in identical twins. Br Med J 1975; 4: 249-251.
16. Andersen OO, Christy M, Arnung K, Buschard K, Christau B, Kromann H et al. Viruses and diabetes. In Bajaj JS ed. Diabetes: Proceedings of the IX Congress of the International Diabetes Federation, New Delhi 1976. Amsterdam, Oxford: Excerpta Medica, 1977: 294-298.
17. Schmidt WAK, Brade L, Muntefering H, Klein M. Course of coxsackie B antibodies during juvenile diabetes. Med Microbiol Immunol 1978; 164: 291-298.
18. West R, Colle E, Belmonte MM, Tingle A, Guttman R, Hynie I et al. Prospective study of Type 1 diabetes mellitus. Diabetes 1981; 30: 584-589.
19. Palmer JP, Cooney MK, Ward RH, Hansen JA, Brodsky JB, Ray CG et al. Reduced coxsackie antibody titres in type 1 (Type 1) diabetic patients presenting during an outbreak of coxsackie B3 and B4 infection. Diabetologia 1982; 22: 426-429.
20. Sakurami T, Nabeya N, Nagaoka K, Matsumori A, Kuno S, Honda A. Antibodies to coxsackie B viruses and HLA in Japanese with juvenile-onset type 1 (Type 1) diabetes mellitus. Diabetologia 1982; 22: 375-377.
21. King ML, Shaikh A, Bidwell D, Voller A, Banatvala JE. Coxsackie-B-virus-specific IgM responses in children with Type 1 (juvenile-onset; type I) diabetes mellitus. Lancet 1983; 1: 1397-1399.
22. Prince MA, Vialettes B, Zevaco-Mattei C, Vague P. Clinical characteristics and etiological markers in Type 1 diabetes associated with an organ-specific autoimmune disease. Acta Diabetologica Latina 1983; 20: 221-229.
23. Banatvala JE, Bryant J, Schernthaner G, Borkenstein M, Schober E, Brown D et al. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset Type 1 diabetes mellitus in Britain, Austria, and Australia. Lancet 1985; 1: 1409-1412.
24. Field LL, McArthur RG, Shin SY, Yoon JW. The relationship between coxsackie-B-virus-specific IgG responses and genetic factors (HLA-DR, GM, KM) in Type 1 diabetes mellitus. Diabetes Res 1987; 6: 169-173.
25. Tuvemo T, Dahlquist G, Frisk G, Blom L, Friman G, Landin-Olsson M et al. The Swedish childhood diabetes study III. IgM against coxsackie B viruses in newly-diagnosed type1 (insulin-dependent) diabetic children-no evidence of increased antibody frequency. Diabetologia 1989; 32: 745-747.
26. Tuszkiewicz-Misztal E. Epidemiologische Faktoren und Antikoerpertiter gegen Coxsackie B-4 Virus im Serum von Patienten mit Diabetes Typ 1. Kinderaertzliche Praxis 1991; 59: 88-91.
27. D'Alessio DJ. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of Type 1 diabetes mellitus. Am J Epidemiol 1992; 135: 1331-1338.
28. Emekdas G, Rota S, Kustimur S, Kocabeyoglu O. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus]. Mikrobiyoloji Bulteni 1992; 26: 116-120.
29. Frisk G, Friman G, Tuvemo T, Fohlman J, Diderholm H. Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 1992; 35: 249-253.
30. Frisk G, Nilsson E, Tuvemo T, Friman G, Diderholm H. The possible role of Coxsackie A and echo viruses in the pathogenesis of type I diabetes mellitus studied by IgM analysis. J Infection 1992; 24: 13-22.
31. Helfand RF, Gary HE, Freeman CY, Anderson LJ, Pittsburgh Diabetes Research Group, Pallansch MA. Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. J Infect Dis 1995; 172: 1206-1211.
32. Hadden DR, Connolly JH, Montgomery DAD, Weaver JA. Coxsackie B virus and diabetes. Br Med J 1972; 4: 729.
33. Hazra DK, Singh R, Wahal PK, Lahiri V, Gupta MK, Jain NK et al. Coxsackie antibodies in young Asian diabetics. Lancet 1980; 1: 877.
34. Gamble DR, Cumming H. Coxsackie B virus and juvenile-onset Type 1 diabetes. Lancet 1985; 2: 455-456.
35. Gamble DR, Taylor KW. Coxsackie B virus and diabetes. Br Med J 1973; 1: 289-290.
36. Hyoty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjalainen J et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995; 44: 652-657.
37. Grandien M, Forsgren M, Ehrnst A. Enteroviruses. In Lennette EH, Lennette DA, Lennette ET eds. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, 7th edn. Washington DC: American Public Health Association, 1995: 279-297.
38. Herrmann KL, Erdman DD. Diagnosis by serologicassays. In Lennette EH, Lennette DA, Lennette ET eds. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, 7th edn. Washington DC: American Public Health Association, 1995: 121-138.
39. Graves PM, Norris JM, Pallansch MA, Gerling IC, Rewers M. The role of enteroviral infections in the development of IDDM: limitations of current approaches. Diabetes 1997; 46: 161-168.
40. Eggers HJ. Accomplishments and challenges in picornavirology as observed by a medical doctor. Clin Diagnostic Virol 1998; 9: 67-76.
41. Frisk G, Diderholm H. Antibody responses to different strains of coxsackie B4 virus in patients with newly diagnosed type 1 diabetes mellitus or aseptic meningitis. J Infection 1997; 34: 205-210.
42. Berger MM, See DM, Aymard M, Lina B. Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction. Clin Diagnostic Virol 1998; 9: 141-143.
43. Andreoletti L, Hober D, Hober-Vandenberghe C, Fajardy I, Belaich S, Lambert V et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol 1997; 52: 121-127.
44. Nairn C, Galbraith DN, Taylor KW, Clements GB. Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet Med 1999; 16: 509-513.
45. Chehadeh W, Weill J, Vantyghem M-C, Alm G, Lefebvre J, Wattre P et al. Increased level of interferon-α in blood of patients with insulin-dependent diabetes mellitus: relationship with Coxsackievirus B infection. J Infect Dis 2000; 181: 1929-1939.
46. Yin H, Berg A-K, Tuvemo T, Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of Type 1 diabetic children at onset. Diabetes 2002; 51: 1964-1971.
47. Salminen K, Sadeharju K, Lonnrot M, Vahasalo P, Kupila A, Korhonen S et al. Enterovirus infections are associated with the induction of β-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003; 69: 91-98.
48. Fuechtenbusch M, Irnstetter A, Jaeger G, Ziegler A-G. No evidence for an association of Coxsackie virus infections during pregnancy and early childhood with development of autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun 2001; 17: 333-340.
49. Coutant R, Palmer P, Carel JC, Cantero-Aguilar L, Lebon P, Bougneres PF. Detection of enterovirus RNA sequences in serum samples from autoantibody-positive subjects at risk for diabetes. Diabet Med 2002; 19: 968-969 (Letter).
50. Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, Diderholm H. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood onset IDDM. Diabetologia 1995; 38: 1371-1373.
51. Dahlquist G, Boman J, Juto P. Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhood-onset IDDM in offspring. Diabetes Care 1999; 22: 364-465 (Letter).
52. Viskari HR, Roivanen M, Reunanen A, Pitkaniemi J, Sadeharju K, Koskela P et al. Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes 2002; 51: 2568-2571.